M 613 (Levetiracetam 250 mg)
Pill imprint M 613 has been identified as Levetiracetam 250 mg.
Levetiracetam is used in the treatment of seizures; epilepsy; new daily persistent headache; hyperekplexia; bipolar disorder (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M 613 (Levetiracetam 250 mg)
- 250 mg
- 10.00 mm
- Prescription only
- Drug Class:
- Pyrrolidine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0820||UDL Laboratories Inc|
|35356-0429||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
Levetiracetam is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...